Suppr超能文献

迷幻剂与心理治疗:以认知行为疗法为常规方法

Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.

作者信息

Yaden David B, Earp Dylan, Graziosi Marianna, Friedman-Wheeler Dara, Luoma Jason B, Johnson Matthew W

机构信息

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Department of Psychology, University of California, Berkeley, Berkeley, CA, United States.

出版信息

Front Psychol. 2022 May 23;13:873279. doi: 10.3389/fpsyg.2022.873279. eCollection 2022.

Abstract

The acute subjective effects of psychedelics are responsive to users' expectations and surroundings (i.e., "set and setting"). Accordingly, a great deal of thought has gone into designing the psychosocial context of psychedelic administration in clinical settings. But what theoretical paradigms inform these considerations about set and setting? Here, we describe several historical, sociological influences on current psychedelic administration in mainstream European and American clinical research settings, including: indigenous practices, new age spirituality from the 1960s, psychodynamic/psychoanalytic approaches, and cognitive-behavioral approaches. We consider each of these paradigms and determine that cognitive-behavioral therapies, including newer branches such as acceptance and commitment therapy (ACT), have the strongest rationale for psychedelic-assisted psychotherapy going forward. Our primary reasons for advocating for cognitive-behavioral approaches include, (1) they avoid issues of cultural insensitivity, (2) they make minimal speculative assumptions about the nature of the mind and reality, (3) they have the largest base of empirical support for their safety and effectiveness outside of psychedelic therapy. We then propose several concepts from cognitive-behavioral therapies such as CBT, DBT, and ACT that can usefully inform the preparation, session, and integration phases of psychedelic psychotherapy. Overall, while there are many sources from which psychedelic psychotherapy could draw, we argue that current gold-standard, evidence-based psychotherapeutic paradigms provide the best starting point in terms of safety and efficacy.

摘要

迷幻药的急性主观效应会受到使用者的期望和周围环境(即“心境与情境”)的影响。因此,在临床环境中设计迷幻药给药的社会心理背景时,人们投入了大量的思考。但是,哪些理论范式为这些关于心境与情境的考量提供了依据呢?在此,我们描述当前欧美主流临床研究环境中对迷幻药给药产生影响的几种历史和社会学因素,包括:本土实践、20世纪60年代的新时代灵性、心理动力/精神分析方法以及认知行为方法。我们对这些范式逐一进行考量,并确定认知行为疗法,包括接纳与承诺疗法(ACT)等较新的分支,对未来的迷幻药辅助心理治疗具有最强的理论依据。我们倡导认知行为方法的主要原因包括:(1)它们避免了文化不敏感问题;(2)它们对心智和现实的本质所做的推测性假设最少;(3)在迷幻药治疗之外,它们在安全性和有效性方面拥有最大的实证支持基础。然后,我们提出认知行为疗法中的几个概念,如认知行为疗法(CBT)、辩证行为疗法(DBT)和接纳与承诺疗法(ACT),这些概念可以有效地为迷幻药心理治疗的准备、疗程和整合阶段提供指导。总体而言,虽然迷幻药心理治疗可以借鉴许多来源,但我们认为,就安全性和疗效而言,当前的金标准、循证心理治疗范式提供了最佳的起点。

相似文献

2
5
Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.虚拟现实作为迷幻辅助心理治疗的调节因素
Front Psychol. 2022 Mar 4;13:813746. doi: 10.3389/fpsyg.2022.813746. eCollection 2022.
8
Compassionate use of psychedelics.同情用药的致幻剂。
Med Health Care Philos. 2020 Sep;23(3):485-496. doi: 10.1007/s11019-020-09958-z.
9
Psychedelic-Assisted Group Therapy: A Systematic Review.迷幻辅助团体治疗:系统评价。
J Psychoactive Drugs. 2019 Apr-Jun;51(2):174-188. doi: 10.1080/02791072.2019.1593559. Epub 2019 Apr 5.

引用本文的文献

2
Small-Molecule Trk Agonists: Where Do We Go from Here?小分子Trk激动剂:我们将何去何从?
J Med Chem. 2025 Aug 14;68(15):15233-15259. doi: 10.1021/acs.jmedchem.4c02365. Epub 2025 Jul 18.

本文引用的文献

1
Psychedelics alter metaphysical beliefs.迷幻剂改变形而上学信仰。
Sci Rep. 2021 Nov 23;11(1):22166. doi: 10.1038/s41598-021-01209-2.
5
Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine.意识、宗教与古鲁:迷幻药疗法的陷阱
ACS Pharmacol Transl Sci. 2020 Dec 16;4(2):578-581. doi: 10.1021/acsptsci.0c00198. eCollection 2021 Apr 9.
6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验